GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varex Imaging Corp (NAS:VREX) » Definitions » Net Current Asset Value

Varex Imaging (Varex Imaging) Net Current Asset Value : $-0.58 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Varex Imaging Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Varex Imaging's net current asset value per share for the quarter that ended in Mar. 2024 was $-0.58.

The historical rank and industry rank for Varex Imaging's Net Current Asset Value or its related term are showing as below:

During the past 11 years, the highest Price-to-Net-Current-Asset-Value Ratio of Varex Imaging was 16.80. The lowest was 16.80. And the median was 16.80.

VREX's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.98
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Varex Imaging Net Current Asset Value Historical Data

The historical data trend for Varex Imaging's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varex Imaging Net Current Asset Value Chart

Varex Imaging Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.06 -4.24 -2.79 -1.03 -0.58

Varex Imaging Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -1.03 -0.58 -0.68 -0.58

Competitive Comparison of Varex Imaging's Net Current Asset Value

For the Medical Devices subindustry, Varex Imaging's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varex Imaging's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Varex Imaging's Price-to-Net-Current-Asset-Value falls into.



Varex Imaging Net Current Asset Value Calculation

Varex Imaging's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Sep. 2023 is calculated as

Net Current Asset Value Per Share(A: Sep. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(658.3-668.6-13.3-0)/40.5296
=-0.58

Varex Imaging's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2024 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(651.9-661.5-14.1-0)/40.6186
=-0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Varex Imaging  (NAS:VREX) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Varex Imaging Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Varex Imaging's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Varex Imaging (Varex Imaging) Business Description

Traded in Other Exchanges
Address
1678 South Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.
Executives
Kimberley E. Honeysett officer: Vice President and Secretary 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Jay K. Kunkel director 21557 TELEGRAPH ROAD, SOUTHFIELD MI 48033
Ruediger Naumann-etienne director
Kathleen Bardwell director 9 BLACKBERRY DRIVE, HUDSON OH 44236
Sunny Sanyal director, officer: President and CEO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Kevin Bruce Yankton officer: Controller & CAO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Andrew Hartmann officer: SVP Sales & Marketing, Medical 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Timothy E Guertin director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Shubham Maheshwari officer: Chief Financial Officer C/O VEECO INSTRUMENTS INC., 1 TERMINAL DRIVE, PLAINVIEW NY 11803
Brian W Giambattista officer: SVP and GM, X-ray Detectors 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT 84104
Erich R Reinhardt director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Mark S. Jonaitis officer: SVP and GM, X-Ray Sources 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Clarence R Verhoef officer: SVP & Chief Financial Officer VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 95035
Rosebrough Walter M Jr director 5960 HEISLEY ROAD, MENTOR OH 44060
Carl E. Lacasce officer: SVP, Sales & Marketing 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104